Trial intelligence / Profile preview

Danggui Dysmenorrhea Granules for Primary Dysmenorrhea (Qi Stagnation and Blood Stasis Pattern)

CTR20131781Phase 2Completed

Sponsor
Beijing Kaijin Technology
Start
May 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Danggui Tongjing Granules in primary dysmenorrhea (PD), sponsored by Beijing Kaijin Technology. Started May 2014; status: completed.

02

Drugs

Danggui Tongjing Granules
03

Conditions

primary dysmenorrhea (PD)

Beyond the preview

Go deeper on CTR20131781.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20131781.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call